Ingredion Inc
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $7.2B | $7.4B | $8.2B | $7.9B | $6.9B |
| Cost of revenue | $5.4B | $5.6B | $6.4B | $6.5B | $5.6B |
| Gross profit | $1.8B | $1.8B | $1.7B | $1.5B | $1.3B |
| Research and development | $71.0M | $67.0M | $63.0M | $52.0M | $43.0M |
| Operating income | $1.0B | $883.0M | $957.0M | $762.0M | $310.0M |
| Pretax income | $974.0M | $931.0M | $839.0M | $668.0M | $248.0M |
| Income tax expense | $238.0M | $277.0M | $188.0M | $166.0M | $123.0M |
| Net income | $729.0M | $647.0M | $643.0M | $492.0M | $117.0M |
| Balance Sheet | |||||
| Cash and equivalents | $1.0B | $997.0M | $401.0M | $236.0M | $328.0M |
| Current assets | $3.5B | $3.4B | $3.4B | $3.3B | $2.7B |
| Total assets | $7.9B | $7.4B | $7.6B | $7.6B | $7.0B |
| Current liabilities | $1.3B | $1.3B | $1.8B | $1.9B | $1.5B |
| Total liabilities | $3.5B | $3.6B | $4.0B | $4.3B | $3.8B |
| Total debt | $1.8B | $1.8B | $2.2B | $2.5B | $2.0B |
| Stockholders' equity | $4.3B | $3.8B | $3.5B | $3.1B | $3.1B |
| Cash Flow Statement | |||||
| Cash from operations | $944.0M | $1.4B | $1.1B | $152.0M | $392.0M |
| Depreciation and amortization | $222.0M | $214.0M | $219.0M | $215.0M | $220.0M |
| Stock-based compensation | $40.0M | $37.0M | $33.0M | $29.0M | $23.0M |
| Capital expenditure | $433.0M | $295.0M | $314.0M | $300.0M | $300.0M |
| Free cash flow | $511.0M | $1.1B | $743.0M | -$148.0M | $92.0M |
| Dividends paid | $211.0M | $210.0M | $194.0M | $181.0M | $184.0M |
| Impairments | $8.0M | $109.0M | $10.0M | $0 | — |
Shares outstanding 63.1M · Free float 93.9%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.